Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We would like to congratulate Tariq Khoyratty, who has been appointed as a Celgene Fellow to study the link between neutrophil chromatin organisation in rheumatic patients and their ability to form pathogenic extracellular traps.

Recent evidence suggests an essential contribution of neutrophils in immunity, inflammation and cancer that extend far beyond their well-known anti-microbial responses. This evidence includes their ability to release extracellular DNA structures. The release of extracellular DNA leads to externalizing enhanced levels of putative autoantigens, and is considered to be particularly relevant to neutrophil deleterious roles in rheumatic diseases. This phenomenon is currently collectively referred to as neutrophil extracellular trap (NET) formation.

PAD4 is an enzyme capable of citrullinating proteins that is being considered as an interesting therapeutic target in rheumatic disorders. The primary interest is to determine whether PAD4 inhibition impacts NET formation in human neutrophils in response to disease-relevant stimuli and to determine whether sub-populations of patients are more prone to citrullination-associated NETosis and thus more likely to respond to a PAD4 inhibitor. Mechanistically, NET formation has been linked to a programmed genome disassembly that is precisely organised and sequence programmed at the level of chromatin organisation.

Speaking of the award, Tariq commented “Ultimately, our aim is to define an early signature in peripheral neutrophils that would correlate with disease severity and propensity to form NETs and can easily be detected in human serum or blood.”

Tariq will be based primarily in the Kennedy Institute and work under the supervision of Prof Irina Udalova and Raashid Luqmani

The fellowship starts in November 2017 and runs for 36 months.

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.